GRM1 and central nervous system cancer: mGluR1, mGluR2, and mGluR3 signaling have been implicated in promoting glioma cells tumorigenicity and metastatic potentials via activated MAPK and PI3K/AKT pathways (Table 1) [144,151,152,153,160].